Angina bullosa hemorrhagica: a case report Authors: Sally El-Haddad, Fatema Akhter, Dina H Younes Published: 2026 ABSTRACT AbstractBackgroundAngina bullosa hemorrhagica (ABH) is a rare, benign, and underdiagnosed oral mucosal condition characterized by the sudden appearance of blood-filled blisters. It is often misdiagnosed or underreported due to its self-limiting nature and lack of specific markers. This case contributes to the growing recognition of ABH by documenting its recurrent manifestation at an unusual site (tongue). It is reported to highlight the importance of avoiding misdiagnosis and unnecessary investigations. Additionally, it contributes to the limited literature on ABH in Egypt and supports established clinical diagnosis criteria.Case presentationA 56-year-old Egyptian male with no significant medical history presented with a painless, dark-purple blood-filled blister on the right side of tongue. He had experienced similar episodes over the past 2 years. Examination showed a soft, non-blanching bulla that spontaneously ruptured, leading to mild erosion that healed within 10 days. Normal blood and coagulation tests led to a diagnosis of ABH. The patient was reassured and prescribed chlorhexidine 0.12% mouthwash, and educated about the benign nature and recurrence potential of the condition.ConclusionThis case underscores the importance of raising awareness about ABH to prevent misdiagnosis and unnecessary procedures. ABH is a self-limiting, recurrent oral lesion that can occur in atypical sites like the tongue, even without systemic risk factors. Diagnosis is primarily clinical, and recognizing its self-limiting nature is key for effective patient management.Keywords: Angina bullosa hemorrhagica, Blood filled, Case report, Hemorrhagic blister, Painless blister, Ventro-lateral border of tongue Background Angina bullosa hemorrhagica (ABH) was first referred to as traumatic oral hemophlyctenosis by Balina from Argentina in 1933. In 1967, Badham was the first to use the term ABH to describe an uncommon mucosal lesion of unknown origin, characterized by fleeting blood-filled blisters [1]. It could be recognized by various other names, including localized oral purpura and stomatopompholyx hemorrhagica [2]. Although the exact cause remains unclear, ABH appears to be multifactorial, with trauma identified as the primary triggering factor. Other factors like consuming hot drinks and oily food items can also contribute to the formation of ABH. This is one of the reasons that ABH is more commonly seen in the Indian subcontinent [3]. It could be developed due to inhaled steroids or underlying systemic conditions, including diabetes mellitus and hypertension [4, 5]. It was reported that 44.4% of ABH cases had diabetes mellitus, hyperglycemia, and/or a family history of diabetes [6]. It has a prevalence rate of 0.03% [7, 8] with female predominance of 1.4:1 [9, 10], affecting middle-aged to elderly adults with a mean age of 55.4 years [5, 9]. However, it may be underdiagnosed due to the clinicians’ lack of knowledge and its self-limited nature with a spontaneously favorable prognosis [11]. Most of the lesions occur on the soft palate, followed by the buccal mucosa and lateral border of the tongue [12, 13]. However, they do not involve the masticatory mucosa [12, 14]. Clinically, ABH may develop as a single episode or recurrent episodes of asymptomatic solitary or multiple lesions [12] characterized by small deep red to purple-colored bullae with ecchymotic halo that measure only a few millimeters or may be larger [13]. The bullae appear suddenly at onset, mostly due to minor trauma. Soon, the roof will collapse spontaneously, evacuating blood, leaving an irregular ulcer that induces pain and a burning sensation. Eventually, it heals spontaneously in a week to 10 days without scarring. Differential diagnosis of ABH includes vesiculobullous lesions, such as pemphigus vulgaris, bullous pemphigoid, epidermolysis bullosa acquisita, linear IgA dermatosis, amyloidosis, bullous oral lichen planus or hematological diseases, such as von Willebrand disease, thrombocytopenia, and leukemia [9, 15]. In 2019, Ordioni et al. [9] proposed nine diagnostic criteria for ABH diagnosis that consist of: Clinically noticeable hemorrhagic blister or erosion with a history of bleeding in the oral mucosa Clinically noticeable hemorrhagic blister or erosion with a history of bleeding in the oral mucosa Exclusively oral or oropharyngeal localization Exclusively oral or oropharyngeal localization Palatal location Palatal location Triggering event or promoting factor (food intake) Triggering event or promoting factor (food intake) Recurrent lesions Recurrent lesions Favorable evolution without leaving a scar in a few days Favorable evolution without leaving a scar in a few days Painless injury, or tingling or burning sensation Painless injury, or tingling or burning sensation Normal platelet count and coagulation test Normal platelet count and coagulation test Negative DIF results Negative DIF results Patients with ABH typically fulfill six out of those nine key diagnostic criteria. Based on the clinical presentation and lesion progress of ABH, the treatment would be symptomatic with patient assurance [9]. Analgesics with chlorhexidine 0.12–0.2% mouth wash can be provided. However, large intact lesions, on the soft palate, would be incised and drained to avoid a possible obstruction of the upper aerodigestive tract [9]. Ascorbic acid and citro-flavonoids may be administered to prevent recurrences [11]. These diagnostic criteria are primarily derived from clinical assessment, facilitating a reliable diagnosis without the indiscriminate use of invasive or costly ancillary investigations. Case presentation A 56-year-old Egyptian man presented in outpatient clinic, Faculty of Dental Medicine, Zagazig University, Egypt, with a sudden onset of blood-filled blister on the right ventrolateral border of the tongue (Fig. 1). He was complaining of tongue discomfort while eating. He noticed an enlarged dark-purple swelling on the lateral border of the tongue that motivated him to quickly seek for treatment and diagnosis. The patient is an employee with high-level education, married, and lives in a rural area. Patient reported a history of previously similar episodes of the lesion on the same site of tongue and also in the palate, but each time, since 2 years ago. The swelling soon burst within a day, then it heals uneventfully within 10 days. There was no contributory medical history of the patient or his relatives. Hemorrhagic blister on the right Extra-oral examination revealed no abnormality with normal patient appraisal and mental acuity. On clinical examination, there was a solitary blood-filled blister measuring approximately 1.5 cm on the right ventrolateral border of the tongue. On palpation, the blister felt soft, smooth, tenderless, and movable in relation to the underlying tissues. It did not blanch upon diascopy examination. A list of differential diagnoses was proposed with the working diagnosis of ABH based on the history of previous episodes of recurrence and clinical presentation of the lesion. CBC with cell differential was requested and the patient was scheduled for excisional biopsy to check for vesiculobullous lesions. Chlorhexidine (0.12%) mouthwash was prescribed three times a day. The results of CBC were normal (as shown in Table 1) with no thrombocytopenia or thrombopathy. A coagulation assessment was performed that revealed normal prothrombin time, partial thromboplastin time, and bleeding time. So, bleeding diathesis was ruled out. Table 1Patient laboratory investigation resultsLaboratory testValueUnitReference rangeHemoglobin14.9g/dL13.5–17.5Platelet count170X109/L150–450Partial Thromboplastin31.5Seconds26–40Prothrombin time13.1Seconds11.7–14.2INR1.05–0.87–1.12HB A1C%5.4%4–5.7 Patient laboratory investigation results Fortunately, after returning home and while talking and pressing tongue against his teeth, the bulla was burst and evacuated blood with a resulting mild painful erosion (Fig. 2). The patient was advised to keep coming to the clinic to monitor and track the progression of the lesion (Figs. 3 and 4). A spontaneous healing without scarring approximately 10 days later was achieved (Fig. 5, Table 2). Hemorrhagic blister after 3 hours post ventrolateral border of the tongue rupture Hemorrhagic blister after 1 day of post rupture Hemorrhagic blister after 1 week of post rupture Hemorrhagic blister site after 10 days post rupture showing complete healing Table 2Case timelineTime pointEvent/finding2 years priorFirst episode of spontaneous blood-filled blister on the palate and tongueIntermittent over 2 yearsRecurrent episodes of similar lesions in the same oral sites, self-healing within ~ 10 daysDay 0 (Presentation)56-year-old male presents with a painless, dark-purple blister (~ 1.5 cm) on the right ventrolateral border of the tongue. Chief complaint: discomfort while eatingDay 0 (Examination)Clinical exam showed soft, non-blanching, mobile hemorrhagic blister without signs of inflammation. Differential diagnoses consideredDay 0 (Investigations)CBC and coagulation profile ordered: all results within normal limits (no thrombocytopenia or coagulopathy)Day 0 (Intervention)Chlorhexidine mouthwash prescribed. Excisional biopsy scheduled. Patient educated and reassuredSame day (Post-visit)Lesion ruptures spontaneously at home during speech and tongue movement, leaving mild erosionDays 1–7Erosion monitored through follow-up. Gradual improvement observedDay 10Complete healing of the lesion with no scarring. Diagnosis of ABH confirmed based on clinical criteria (met 8/9)Post-resolutionPatient advised on recurrence potential and given written educational materials about ABH and airway risks Case timeline Based on the relevant positive findings (history of recurrent episodes of blood-filled blisters over the past 2 years, affecting both the tongue and palate, recent sudden-onset hemorrhagic blister on the right ventrolateral border of the tongue, discomfort during eating reported, spontaneous rupturing and healing within 10 days without scarring, and no identifiable traumatic incident at onset), examination findings (single 1.5-cm hemorrhagic bulla on the right ventrolateral border of the tongue that was painless, soft, smooth, non-blanching, and mobile with no signs of inflammation, no surrounding tissue compromise, negative diascopy test that ruling out vascular malformation), and results of investigations (normal CBC and coagulation profile), we rolled out thrombocytopenia, bleeding disorders, and systemic illness. Additionally, the lesion ruptured spontaneously; site monitored through follow-up showing complete healing within 10 days without complications or delayed resolution. The patient followed prescribed use of chlorhexidine mouthwash three times daily without missing doses. He complied with follow-up visits and follow-up advice regarding lesion monitoring and recurrence risk. No discomfort, irritation, or side effects were reported from the use of chlorhexidine mouthwash. The patient tolerated the lesion rupture and healing process well without the need for analgesics. The patient was assured and was given an information sheet that describes the nature of the lesion, causative factors, recurrent nature, prognosis, treatment, and a warning if it occurs on the pharynx, it may cause dyspnea, and circumspection should be considered. The patient expressed relief and increased confidence in handling future episodes, especially after receiving educational material and guidance on when to seek urgent care (for example, if the lesion occurs in the throat). Overall, the patient appreciated the clear communication, the avoidance of unnecessary procedures, and the supportive care approach. Direct immunofluorescence was not done—not required as the clinical diagnosis fulfilled 8/9 ABH diagnostic criteria. So, the patient diagnosed with angina bullosa hemorrhagica was confirmed avoiding unnecessary invasive investigations, such as biopsy or immunofluorescence. Serial clinical photographs were taken to track the lesion from rupture through complete healing. Patient was instructed to report any future lesions promptly, especially those involving the oropharynx, for early intervention if airway risk arises. Discussion and conclusion Badham first described angina bullosa hemorrhagica (ABH) 1967, yet it is a misnomer because it is neither associated with angina nor pain. However, it may alike angina when the blister at the pharynx enlarges and causes a choking sensation. This lesion does not induce any inflammatory reactions or manifestations. So, the nomenclature “benign hemorrhagic bullous stomatitis,” as proposed by Antoni-Bach et al. appears to be more precisely describing its clinical profile [16]. It is characterized by recurring hemorrhagic blister on the oropharyngeal mucosa, especially in trauma-prone areas [1]. It is reported that it is considered as rare occurrence; however, it is likely to be underdiagnosed due to frequent misinterpretation by physicians and its swift, self-resolving nature [11]. It occurs most frequently in the soft palate. This may be attributed to increased blood flow to the soft palate via parasympathetic reflex vasodilatation during mastication [17]. Patients commonly complain of slight discomfort while few patients reported xerostomia, tingling and tightness, difficulty in swallowing, choking, gagging reflex, or air way obstruction if the lesions are large and seen in Faucial pillars, arytenoids, oropharynx, posterior pharynx, epiglottis, or esophagus [18]. In a systematic review, conducted by Ordioni et al. [9] that included a comprehensive analysis, they reported a considerable proportion of ABH cases (one-third) occurred in individuals without any preexisting medical conditions. Among patients with documented comorbidities, the prevalence of hypertension (21%), diabetes mellitus (15%), and inhaled corticosteroid use (7%) was either on par with or lower than the expected incidence in the general population aged 55 years. These findings do not provide compelling evidence to establish a definitive etiological link between ABH and these systemic conditions. Furthermore, only 3.5% of cases reporting a familial history of ABH reflects an insufficient basis to suggest a hereditary predisposition or a discernible genetic inheritance pattern. Others highlighted a potential correlation, noting that 44% of their 54 ABH reported cases exhibited an association with diabetes, hyperglycemia, and/or a familial predisposition to diabetes [6]. There is no reported prevalence of ABH in a specific race; however, in Egypt, it is very rare to encounter, and there is insufficient data describing its occurrence or incidence. In our case, the patient presented with clinically evident hemorrhagic bullae with a history of recurrent lesion on the soft palate. The lesions exhibited self-limiting behavior, resolving spontaneously without scarring, while laboratory findings confirmed normal platelet counts and coagulation profiles. Collectively, the patient met eight out of the nine established diagnostic criteria for ABH [9]. This case highlights the importance of clinical recognition to prevent unnecessary excisions, immunologic testing, or patient anxiety. Although ABH often occurs on the soft palate, this case involved recurrent lesions on the tongue, which is less frequently reported. Normal lab findings in the setting of hemorrhagic lesion reinforce that ABH is not related to coagulation defects and does not require extensive workup. Awareness of potential airway risk reinforces the need for early recognition and patient education to prevent rare but serious complications like airway obstruction in larger oropharyngeal lesions. In a few cases, a large lesion located in the throat may obstruct the airway if it does not rupture on its own. Our case report describes rare oral site involvement of the ventrolateral border of the tongue, which is not the most common site. Additionally, multiple recurrence history over 2 years reflects the longitudinal presentation that may add to the understanding of ABH's natural history. The diagnosis fulfilled 8/9 of Ordioni Criteria. Absence of common predisposing factors, with no systemic illness, trauma, or medication, underscores ABH’s idiopathic nature in some patients. Figure 6 illustrates a novel, stage-based classification of the clinical evolution of ABH, providing a structured visual framework that is currently lacking in the literature. The figure delineates five distinct stages of lesion progression: from the initial tense, hemorrhagic blister (Stage 1), through spontaneous rupture (Stage 2), superficial ulceration (Stage 3), early re-epithelialization (Stage 4), to complete mucosal healing without scarring (Stage 5). This sequential documentation offers enhanced diagnostic clarity and facilitates clinical monitoring over time. While ABH is generally recognized as a self-limiting condition with rapid healing, the addition of a stage-wise classification grounded in real-time clinical photography introduces a new dimension for both academic study and clinical reference. Furthermore, this classification may assist clinicians in differentiating ABH from similar oral pathologies—particularly vesiculobullous diseases and post-traumatic hematomas—by emphasizing the lesion’s predictable natural course and benign behavior. Given the rarity and under-recognition of ABH, especially in atypical sites like the ventrolateral tongue, this structured staging system contributes meaningfully to the standardization of clinical documentation and patient management. Illustrates the clinical progression and healing stages of angina bullosa hemorrhagica (ABH) on the dorsal surface of the tongue: 1. Stage 1 (initial stage)—blood blister formation: ** A tense, dark-red hemorrhagic blister develops suddenly on the lateral tongue surface due to minor trauma and subepithelial hemorrhage. 2. Stage 2 (rupture stage): the blister ruptures spontaneously within 24–48 hours, leaving a raw, bleeding surface. 3. Stage 3 (ulcer stage): A superficial ulcer forms at the previous blister site within 2 days, often accompanied by mild discomfort. 4. Stage 4 (early healing): epithelialization begins, and the ulcer surface appears reduced in size with minimal inflammation within 3–6 days. 5. Stage 5 (complete healing): full mucosal recovery with normal color and texture, leaving no scar after 7–10 days. Arrows indicate the chronological sequence of lesion evolution and healing Treatment strategies include simple monitoring, follow-up, and palliative care as the lesion may not be attributed to any systemic conditions, blood diathesis, dermatological pathologies, or even true vasculitis. Despite the possibility that some medical conditions, such as diabetes mellitus, hypertension, and the use of inhaled steroids, can be risk factors for ABH, clinicians should be aware of ABH and consider the likelihood of its association with underlying conditions. Aligning with our case, Mortazavi et al. [19] reported that while ABH predominantly manifests on the palate, the previous episode of our patient, it can also affect other oral sites, including the tongue, as seen in the current occurrence. Additionally, it was emphasized that trauma induced by eating could weaken the epithelial-connective tissue adhesion and so being the most commonly implicated precipitating factor [9]. This finding is in concordance with our case, as the lesion in our patient similarly emerged during mastication, further reinforcing the role of mechanical trauma as a primary etiological trigger in ABH development. Another explanation was in 2014, where Ref. [15] suggested that increased vascular fragility or deficiencies in elastin and collagen may contribute to the formation of subepithelial hemorrhages. However, validating this hypothesis necessitates further structural investigations to elucidate the precise pathological mechanisms involved. Differential diagnosis: The differential diagnosis of ABH is broad, so a systematic and meticulous diagnostic approach is essential to accurately distinguish ABH from other clinically overlapping yet pathophysiological distinct conditions [15]. Table 3 summarizes the main differential diagnoses of ABH (for example, autoimmune vesiculobullous diseases, hematologic disorders, traumatic hematoma) with their distinguishing clinical or immunopathologic features. Table 3The differential diagnosis of angina bullosa hemorrhagica (ABH)The lesionKey clinical featuresHistopathologic featuresImmunopathologic findingsDistinguishing points from ABHAngina bullosa hemorrhagica (ABH)Sudden onset of painless, blood-filled bullae; typically on soft palate; rupture within hours; heals without scarringSubepithelial cleft with hemorrhage; minimal inflammationNegative direct immunofluorescence (DIF)Benign, self-limiting; no systemic diseasePemphigus vulgarisPainful erosions; fragile bullae; positive Nikolsky signIntraepithelial acantholysisIntercellular IgG (Painful erosions, intraepithelial splitBullous pemphigoidTense bullae; may involve oral mucosa; often pruritic; elderly patientsSubepithelial blister with eosinophilsLinear IgG and C3 along basement membraneChronic course; positive DIFMucous membrane pemphigoidRecurrent oral bullae; gingival desquamation; possible scarringSubepithelial splitLinear IgG/IgA/C3 at basement membraneScarring, chronicity, positive DIFEpidermolysis bullosa acquisitaTrauma-induced bullae; possible scarringSubepithelial blisterIgG against type VII collagenChronic, scarring, systemic associationOral Lichen Planus (bullous type)Erosive or bullous lesions with Wickham striaeBand-like lymphocytic infiltrateFibrinogen at basement membraneChronic inflammation, reticular lesionsThrombocytopeniaPetechiae, ecchymoses, spontaneous oral bleedingNonspecific hemorrhageAbnormal platelet countSystemic bleeding tendencyCoagulation disorders (for example., hemophilia)Recurrent bleeding, hematomasNonspecific hemorrhageAbnormal coagulation profilePositive hematologic findingsLeukemiaGingival enlargement, petechiae, ulcersLeukemic infiltrationAbnormal CBCSystemic symptomsTraumatic hematomaLocalized swelling following traumaHemorrhage without blister formationNegative DIFClear trauma historyAllergic contact stomatitisErythema, edema, vesicles; burning sensationSpongiosis, inflammationNegative DIFSymptomatic, diffuse reactionHerpes simplex infectionPainful vesicles progressing to ulcersViral cytopathic changesPositive viral testsPainful, recurrent, viral etiology The differential diagnosis of angina bullosa hemorrhagica (ABH) A rigorous diagnostic approach is imperative to exclude autoimmune disorders or coagulopathies that could contribute to abnormal bleeding tendencies. Due to the fragile nature of these lesions, they often rupture within minutes to hours, leading patients to seek medical attention for post-bullous erosions, which can obscure the clinical diagnosis, so it may be conceptualized as a superficial hematoma that undergoes spontaneous rupture due to its delicate epithelial covering and the mechanical stresses and friction inherent to the oral environment. Nevertheless, it also can be distinguished from post-traumatic hematomas of the cheek or tongue resulting from accidental biting, as ABH typically manifests asymptomatically, with no recollection of a specific traumatic incident reported by the patient at the time of onset. In this case, biopsy and direct immunofluorescence were not necessary due to the sudden onset, painless nature, characteristic appearance of blood-filled blisters, rapid spontaneous resolution, and the absence of recurrence or systemic symptoms. These features are typical of ABH. Histopathological examination and direct immunofluorescence tests are usually reserved for instances that present atypical characteristics, such as persistent or recurrent lesions, significant pain, scarring, extraoral involvement, or when it is not possible to confidently rule out an autoimmune vesiculobullous disorder based on clinical evaluation. In these situations, a biopsy is crucial for differentiating ABH from conditions like mucous membrane pemphigoid or pemphigus vulgaris, which have distinct histopathologic and immunopathologic characteristics. The pathophysiology of ABH is not completely understood; however, it is generally regarded as a benign, localized condition. It typically occurs due to a combination of minor mucosal trauma and increased fragility of the epithelial tissue. Activities such as chewing, dental procedures, or consuming sharp foods are believed to cause microtrauma, which can lead to the rupture of superficial subepithelial capillaries, especially in areas of the oral mucosa—like the soft palate—that are thin and poorly supported. This results in the sudden development of blood-filled subepithelial blisters without significant inflammation or immune-mediated damage. The absence of immunopathologic findings indicates that ABH does not have an autoimmune mechanism, distinguishing it from other vesiculobullous disorders that may have a similar clinical presentation. Management of ABH is primarily symptomatic, with a focus on patient reassurance and supportive care. If any causative factor was identified, it should be eliminated, such as irritants or traumatic components. Analgesics may be administered for pain relief, while topical antiseptic treatments, such as chlorhexidine (0.12–0.2%) can aid in maintaining oral hygiene and preventing secondary infection. Combination therapy of ascorbic acid and citro-flavonoids (200 mg twice daily) might play a role in reducing the recurrence of ABH, potentially by reinforcing vascular integrity and enhancing mucosal resilience [6]. Recurrence rate is reported to be 30% [13], which represents a fairly high recurrent rate, so the patient should be advised to avoid any identifiable causative factors. The patient should be made aware of the complications and advised to report immediately if symptoms persist as bullae have to be ruptured under supervision, where the free blood in the larynx requires intubation of the trachea by either fiber optic endoscopy or direct laryngoscopy, or surgical tracheostomy [20]. To conclude, angina bullosa hemorrhagica (ABH) remains an underreported entity within the scientific literature, with existing studies being highly heterogeneous and predominantly comprising low-evidence case reports or small case series, often marred by incomplete or unreported data. Despite its benign nature and self-limiting course in most instances, ABH exhibits clinical and histopathological parallels with more severe conditions, necessitating meticulous diagnostic scrutiny. This case raises the hypothesis of “Recurrent ABH without systemic comorbidities may be associated with subclinical trauma or epithelial fragility in susceptible oral mucosal sites such as the tongue.” Timely diagnosis based on clinical features avoids unnecessary interventions and patient distress. The case contributes to the limited literature on ABH in non-palatal locations and highlights the need for clinician awareness to improve diagnostic confidence and guide conservative management. Clinical implication Angina bullosa hemorrhagica is a benign and self-limiting oral condition that can be diagnosed reliably based on its distinctive clinical features. It is important to recognize its sudden onset, the presence of painless, blood-filled blisters (bullae), and the fact that these lesions resolve spontaneously. This understanding helps to prevent unnecessary investigations and reduces patient anxiety. Biopsies and immunofluorescence tests should only be performed for atypical, persistent, or painful lesions to rule out autoimmune or systemic disorders. Limitations Absence of histopathological confirmation due to spontaneous lesion rupture prior to scheduled biopsy may limit academic validation. Single case report limits generalizability and does not allow definitive conclusions about prevalence or causative factors. Lack of long-term follow-up data on recurrence beyond the documented episode is a major challenge. Acknowledgements This research was supported by the General Directorate of Scientific Research and Innovation, Dar Al Uloom University, SA, through the Scientific Publishing Funding Program. The authors also acknowledge Zagazig University, Egypt, which contributed to the successful completion of this work. Author contributions D. Y. managed the case, wrote the draft manuscript, literature review, revision and approved the final manuscript. S. E and F. A: writing and revision of the final manuscript. Funding No funding. Availability of data and materials The data used in this study are available from the corresponding author upon a reasonable request. Declarations Ethics approval and consent to participate The study obtained ethical approval from the Institutional Review Board of Zagazig University, Egypt, following the ethical guidelines as outlined in the Declaration of Helsinki. Informed written consent was secured from the participant. Consent for publication Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests The authors declare that there is no conflict of interest regarding this case report. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data used in this study are available from the corresponding author upon a reasonable request.